Luther King Capital Management (LKCM)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Buy
10,397
+87
+0.8% +$9.35K ﹤0.01% 398
2025
Q1
$1.04M Buy
10,310
+60
+0.6% +$6.05K ﹤0.01% 405
2024
Q4
$916K Sell
10,250
-13
-0.1% -$1.16K ﹤0.01% 410
2024
Q3
$860K Buy
10,263
+73
+0.7% +$6.12K ﹤0.01% 420
2024
Q2
$785K Hold
10,190
﹤0.01% 426
2024
Q1
$698K Hold
10,190
﹤0.01% 440
2023
Q4
$589K Hold
10,190
﹤0.01% 441
2023
Q3
$538K Sell
10,190
-164
-2% -$8.66K ﹤0.01% 456
2023
Q2
$560K Buy
10,354
+79
+0.8% +$4.27K ﹤0.01% 464
2023
Q1
$514K Buy
10,275
+25
+0.2% +$1.25K ﹤0.01% 460
2022
Q4
$474K Sell
10,250
-149
-1% -$6.89K ﹤0.01% 460
2022
Q3
$403K Hold
10,399
﹤0.01% 472
2022
Q2
$388K Sell
10,399
-538
-5% -$20.1K ﹤0.01% 508
2022
Q1
$484K Buy
10,937
+239
+2% +$10.6K ﹤0.01% 483
2021
Q4
$454K Sell
10,698
-158
-1% -$6.71K ﹤0.01% 505
2021
Q3
$471K Buy
10,856
+206
+2% +$8.94K ﹤0.01% 500
2021
Q2
$455K Sell
10,650
-67
-0.6% -$2.86K ﹤0.01% 513
2021
Q1
$414K Sell
10,717
-276
-3% -$10.7K ﹤0.01% 478
2020
Q4
$395K Sell
10,993
-15,539
-59% -$558K ﹤0.01% 474
2020
Q3
$1.01M Hold
26,532
0.01% 328
2020
Q2
$932K Sell
26,532
-1,380
-5% -$48.5K 0.01% 328
2020
Q1
$911K Sell
27,912
-675
-2% -$22K 0.01% 314
2019
Q4
$1.29M Buy
28,587
+281
+1% +$12.7K 0.01% 325
2019
Q3
$1.15M Buy
28,306
+10,010
+55% +$407K 0.01% 329
2019
Q2
$786K Sell
18,296
-21,466
-54% -$922K 0.01% 356
2019
Q1
$1.53M Hold
39,762
0.01% 298
2018
Q4
$1.41M Buy
39,762
+22
+0.1% +$777 0.01% 293
2018
Q3
$1.53M Buy
39,740
+15,205
+62% +$585K 0.01% 314
2018
Q2
$802K Buy
+24,535
New +$802K 0.01% 373